Gene therapy is a burgeoning field offering potential cures for genetic and acquired disorders. Nonviral gene delivery approaches have gained traction as alternatives to viral vectors due to their advantages such as reduced immunogenicity, lower toxicity, and potential tissue specificity. Despite promising results in animal models and clinical trials, the efficiency of nonviral gene delivery remains a significant challenge. This review focuses on the principles, limitations, and recent progress in nonviral gene delivery methods, emphasizing the development of chemical and physical strategies to enhance therapeutic nucleic acid delivery in vivo.
Gene transfer is essential in studying gene function, establishing disease models, and exploring therapeutic applications. Naked DNA molecules face barriers such as nuclease degradation and inability to efficiently enter cells. Recombinant viruses have been traditionally used for gene transfer but come with limitations like immune responses and integration issues. Nonviral methods utilize synthetic or natural compounds to deliver DNA into cells, offering advantages in safety, tissue specificity, and ease of production. However, nonviral approaches are generally less efficient than viral methods, with short-lived gene expression being a common challenge.
Various barriers hinder efficient gene delivery, including anatomical obstacles, extracellular nuclease degradation, and cellular entry limitations. Strategies to overcome these barriers include the use of fusogenic molecules to disrupt endosomes, altering osmotic pressure for endosomal escape, and enhancing intracellular trafficking towards the nucleus. Achieving sustained gene expression is vital, with factors like promoter silencing, immune responses, and DNA methylation affecting the duration of transgene expression.
Physical methods such as localized injection, jet injection, hydrodynamic delivery, gene gun, electroporation, and sonoporation have shown promise in enhancing gene transfer efficiency. Chemical vectors like cationic lipids and polymers form complexes with DNA to facilitate cellular uptake and intracellular delivery. Lipofection, a widely studied nonviral gene delivery method, utilizes cationic liposomes to protect DNA and promote cell interaction. Strategies such as surface shielding with polymers and targeted delivery using monoclonal antibodies have been explored to improve transfection efficiency and targeted gene delivery.
Advancements in nonviral gene delivery methods have addressed many limitations, paving the way for more effective and targeted gene therapies. While challenges such as acute toxicity and transient gene expression persist, ongoing research focuses on refining delivery systems to achieve sustained therapeutic outcomes. The future of gene therapy lies in harnessing the potential of nonviral gene delivery approaches to revolutionize treatment options for genetic and acquired diseases.
Key Takeaways:
1. Nonviral gene delivery methods offer advantages over viral vectors, including reduced immunogenicity and potential tissue specificity.
2. Overcoming barriers such as nuclease degradation and cellular entry limitations is crucial for efficient gene transfer.
3. Physical methods like jet injection, electroporation, and sonoporation, along with chemical vectors such as cationic lipids, show promise in enhancing gene delivery efficiency.
4. Strategies like targeted delivery using monoclonal antibodies and surface modification with polymers are being explored to improve gene transfer specificity and duration of expression.
Tags: drug delivery, viral vectors, monoclonal antibodies, formulation, gene therapy
Read more on pmc.ncbi.nlm.nih.gov